Table 3 Association between diagnostic tests and survival time and 180 day mortality risk among people with ICI myocarditis who develop CHB
Diagnostic test | Association with survival | P-value for mortality risk* | N = | |
|---|---|---|---|---|
Spearman’s rho | p-value | (ranksum) | ||
Laboratory tests | ||||
White blood cell count | -0.775 | 0.041 | 0.245 | 7 |
Troponin T | -0.943 | 0.0048 | 0.143 | 6 |
NT pro-BNP | 0.3 | 0.624 | 0.157 | 3 |
Creatine Kinase | 0 | 1.000 | 0.480 | 5 |
AST | -0.306 | 0.504 | 0.699 | 5 |
ALT | -0.487 | 0.268 | 0.699 | 7 |
Albumin | -0.638 | 0.173 | 0.766 | 6 |
ECG at admission | ||||
Ventricular rate | 0.812 | 0.0499 | 0.245 | 6 |
PR interval | 0.290 | 0.637 | 0.643 | 5 |
QRS duration | -0.633 | 0.128 | 0.121 | 7 |
QT interval | 0.479 | 0.277 | 0.241 | 7 |
QTc interval | -0.316 | 0.490 | 0.439 | 7 |
Sokolow Lyon Index | -0.655 | 0.158 | 0.143 | 6 |
Treatment | Exact p-value | |||
IVIG | 0.858 * | 7 | ||
Temporary pacemaker | 0.130 * | 7 | ||
Permanent pacemaker | 0.051* | 7 | ||